US › Healthcare

SIGA Technologies Inc (SIGA)

US · Healthcare · Drug Manufacturers - Specialty & Generic

$3.17-0.63%

Last close · 2026-10-16

Latest quarter · ended 2026-06-30

Revenue

$41.0M

Revenue YoY

-49.5%

Net profit

$12.5M

Profit YoY

-64.9%

EPS

$0.17

Net margin

30.4%

Key statistics

Market cap

$227.8M

Forward P/E

2.9

P/B

1.38

Book value

$2.30

EPS (TTM)

$-0.04

52-week high

$7.56

52-week low

$2.83

50-day MA

$3.15

200-day MA

$4.55

Beta

0.96

Analyst view

with an average price target of $17.53.

Shareholding

Insiders

42.73%

Institutions

50.21%

Largest institutional holders

Fund	Stake
BlackRock Inc	5.83%
Dimensional Fund Advisors, Inc.	3.79%
AltraVue Capital, LLC	3.24%
Vanguard Capital Management, LLC	2.38%
American Century Companies Inc	2.10%
Arrowstreet Capital Limited Partnership	2.05%
Geode Capital Management, LLC	1.97%
First Wilshire Securities Mgmt Inc (CA)	1.86%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for SIGA Technologies Inc — free to start.

Open in the app Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Gilead Sciences Inc Abbott Laboratories Novo Nordisk A/S

Data updated 2026-10-18.